Capstone Investment Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-4,699
Closed -$245K 697
2017
Q3
$245K Buy
+4,699
New +$262K 0.01% 433
2016
Q4
Sell
-6,000
Closed -$267K 1150
2016
Q3
$267K Buy
+6,000
New +$260K 0.01% 633

Other funds holding SYNH

Capstone Investment Advisors's SYNH Position: Q4 2017 in Review

Capstone Investment Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2017, closing a stake of 4,699 shares — an estimated $245K sold.

Capstone Investment Advisors first reported a position in SYNH in Q3 2016 and held it in 2 quarters. The position peaked at $267K in Q3 2016. 194 funds tracked by Wall St. Rank hold SYNH as of Q4 2017.

  • Capstone Investment Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2017 after selling out during the quarter.
  • Capstone Investment Advisors sold 4,699 Syneos Health, Inc. Class A Common Stock shares in Q4 2017, an estimated $245K.
  • Capstone Investment Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2016 and held it in 2 quarters.
  • Capstone Investment Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $267K in Q3 2016.
  • 194 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2017.

Based on Capstone Investment Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.